Financials
- Market Capitalization 485.74 M
- Employee 179
- Founded 2007
- CEO N/A
- Website www.pumabiotechnology.com
- Headquarter Delaware, United States
- FIGI BBG0018YXYX7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
15.6
売上高対価格比率
1.8
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2917 | AGMB AgomAb Therapeutics NV - ADRs representing one | 14.75 USD | +7.98% | +6.58% | +7.27% | +0.34% | 503.97 M USD | ||
| 2926 | PRTA Prothena Corporation plc - Ordinary Shares | 9.60 USD | -0.93% | +6.43% | +14.42% | +13.61% | 492.83 M USD | ||
| 2949 | EDIT Editas Medicine, Inc. - Common Stock | 3.08 USD | 0.00% | -5.23% | +14.50% | +21.26% | 473.03 M USD | ||
| 2955 | AVIR Atea Pharmaceuticals, Inc. - common stock | 5.83 USD | +2.28% | +6.97% | +26.46% | +81.62% | 467.59 M USD |